Literature DB >> 6230005

Difference between young and old patients in characteristics of leukemic cells: older patients have cells growing excessively in vitro, with low antigenicity despite high HLA-DR antigens.

N Giannoulis, C Ogier, R Hast, B Lindblom, A M Sjögren, P Reizenstein.   

Abstract

Fifty-six patients with acute, non-lymphatic leukemia in the initial phase were studied. The poor prognostic signs were excessive in vitro growth, many HLA-DR-positive cells, or a low ratio of leukemic cell antigenicity to HLA-DR positivity and age. The cells from older patients formed more clusters (P less than 0.05), and they had less capacity to stimulate normal allogeneic lymphocytes (P less than 0.05) than those from younger patients. Cells forming many clusters also were more often (P less than 0.01) HLA-DR-positive than those forming few clusters. It is suggested that the prognosis in old patients with acute leukemia is poor in part because their leukemic cells have characteristics different from those of young patients.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6230005     DOI: 10.1002/ajh.2830160203

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  4 in total

1.  Age and the biology of acute myeloid leukemia.

Authors:  H T Hassan
Journal:  Ann Hematol       Date:  1992-03       Impact factor: 3.673

Review 2.  Idarubicin: a pharmacoeconomic evaluation of its use in adult patients with acute myeloid leukaemia.

Authors:  R Whittington; K L Goa
Journal:  Pharmacoeconomics       Date:  1993-10       Impact factor: 4.981

3.  Requirements for the stimulation of allogeneic T lymphocytes by acute non-lymphoblastic leukaemia cells.

Authors:  L K Ashman; G W Kriek; S J Cooper; D E O'Keefe
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

4.  Remission with high erythrocyte sedimentation rates in acute myeloid leukemia is of short duration.

Authors:  A Brizzi; C Ogier; P Reizenstein
Journal:  Blut       Date:  1985-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.